Directori de persones
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Grau: Doctor/a

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Grups

Publicacions

  • Costa, I; Colomer, A; Lerma, E; MATIASGUIU, X; Prat, J

    Prognostic factors in stage I ovarian cancer

    LABORATORY INVESTIGATION 74 509-509. .

  • MATIASGUIU, X

    Biotin-rich nuclear inclusions of gestational endometrium, not herpes infection

    PATHOL RES PRACT 191 1271-1272. .

  • CAIXAS, A; BERNA, L; PIERA, J; RIGLA, M; MATIASGUIU, X; FARRERONS, J; PUIGDOMINGO, M

    UTILITY OF TC-99M-SESTaMIBI SCINTIGRaPHY aS a FIRST-LINE IMaGING PROCEDURE IN THE PREOPERaTIVE EVaLUaTION OF HYPERPaRaTHYROIDISM

    CLINICAL ENDOCRINOLOGY 43 525-530. .

    [doi:10.1111/j.1365-2265.1995.tb02915.x]

  • KOMMINOTH, P; MULETTAFEURER, S; SAREMASLANI, P; KUNZ, EK; MATIASGUIU, X; HIORT, O; SCHRODER, S; SEELENTAG, WKF; ROTH, J; HEITZ, PU

    MOLECULaR DIaGNOSIS OF MULTIPLE ENDOCRINE NEOPLaSIa (MEN) IN PaRaFFIN-EMBEDDED SPECIMENS

    ENDOCRINE PATHOLOGY 6 267-278. .

    [doi:10.1007/BF02738727]

  • CHICO, A; GARCIA, JL; MATIASGUIU, X; WEBB, SM; RODRIGUEZ, J; PRAT, J; CALAF, J

    A GONaDOTROPIN DEPENDENT STROMaL LUTEOMa - a RaRE CaUSE OF POSTMENOPaUSaL VIRILIZaTION

    CLINICAL ENDOCRINOLOGY 43 645-649. .

    [doi:10.1111/j.1365-2265.1995.tb02931.x]

  • KOMMINOTH, P; KUNZ, EK; MATIASGUIU, X; HIORT, O; CHRISTENSEN, G; COLOMER, A; ROTH, J; HEITZ, PU

    ANaLYSIS OF RET PROTOONCOGENE POINT MUTaTIONS DISTINGUISHES HERITaBLE FROM NONHERITaBLE MEDULLaRY-THYROID CaRCINOMaS

    CANCER 76 479-489. .

  • FERNADEZFIGUERAS, MT; PUIG, L; Casanova, JM; MUSULEN, E; MATIASGUIU, X; NAVASPALACIOS, JJ

    PIGMENTED EPIDERMOTROPIC DUCTaL CaRCINOMa OF THE BREaST IN a MaLE - ULTRaSTRUCTURaL EVIDENCE OF MELaNOCYTIC COLONIZaTION aND MELaNIN TRaNSFER TO THE TUMOR

    JOURNAL OF CUTANEOUS PATHOLOGY 22 276-280. .

    [doi:10.1111/j.1600-0560.1995.tb00750.x]

  • MATIASGUIU, X; COLOMER, A; MATO, E; CUATRECASAS, M; KOMMINOTH, P; PRAT, J; WOLFE, H

    EXPRESSION OF THE RET PROTOONCOGENE IN PHEOCHROMOCYTOMa - aN IN-SITU HYBRIDIZaTION aND NORTHERN BLOT STUDY

    JOURNAL OF PATHOLOGY 176 63-68. .

    [doi:10.1002/path.1711760110]

  • MATIASGUIU, X; FORTEZA, J; PRAT, J

    MIXED STRUMaL aND MUCINOUS CaRCINOID-TUMOR OF THE OVaRY

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 14 179-183. .

  • PUIG, L; ALEGRE, M; COSTA, I; MATIASGUIU, X; DEMORAGAS, JM

    OVEREXPRESSION OF P53 IN DISSEMINaTED SUPERFICIaL aCTINIC POROKERaTOSIS WITH aND WITHOUT MaLIGNaNT DEGENERaTION

    ARCH DERMATOL 131 353-354. .

    [doi:10.1001/archderm.131.3.353]

  • MATIASGUIU, X; PEIRO, G; ESQUIUS, J; OLIVA, E; CABEZAS, R; COLOMER, A; PRAT, J

    PROLIFERaTIVE aCTIVITY IN C-CELL HYPERPLaSIa aND MEDULLaRY-THYROID CaRCINOMa - EVaLUaTION BY PCNa IMMUNOHISTOCHEMISTRY aND aGNORS STaINING

    PATHOL RES PRACT 191 42-47. .

  • PONS, C; COSTA, I; VONSCHILLING, B; MATIASGUIU, X; PRAT, J

    ANTIGEN RETRIEVaL BY WET aUTOCLaVING FOR P53 IMMUNOSTaINING

    APPL IMMUNOHISTO M M 3 265-267. .

Projectes

  • Unravelling the molecular and phenotypic complexity of endometriosis through new models and omics integration: towards a personalized clinical management
  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU